Significant findings
Analysis of blood samples revealed that levels of most constituents measured -high-sensitivity Creactive protein (CRP), fibrinogen, serum amyloid A (SAA), serum viscosity, plasminogen activator inhibitor-1, von Willebrand factor and lipid concentrations -were significantly elevated in patients with chronic CHD compared with controls; only albumin levels were not different between the two groups. The highest correlation (r = 0.64) was seen between plasma viscosity and its main determinant, fibrinogen, and between the two classic acute phase reactants, CRP and SAA. 'The correlation was less pronounced if these markers also represented other systems like blood coagulation, fibrinolysis, blood rheology, and endothelial function,' Hoffmeister et al report. After full adjustment, odds ratios for the various markers decreased moderately but still remained substantial and statistically significant. Subjects with levels in the upper tertile in =2 of the inflammatory markers had a strongly increased risk compared with subjects in the lower two tertiles. However, levels of the markers were not found to be related to any of the three disease severity scores applied (clinical 1-to 3-vessel score; American Heart Association extension score, and the Gensini score).
